AMELLO JASON (Chief Financial Officer) reported 1 transaction at CANDEL THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/30/2023ACC: 0001209191-23-056981
Officer· Chief Financial Officer
Since Sep 2022
-20.15K
Net shares
Net seller
$18.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
20.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20.15K
Price / share
$0.90
Trade value
$18.14K
% of position
9.1%
11/28/2023
222.16K→202.01K
Total
Net shares
−20.15K
Net value
-$18.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2023 | F · Tax Withholding | −20.15K | $0.90 | $18.14K | 9.1% | 222.16K | 202.01K |
| Total | −20.15K | -$18.14K | ||||||
Derivative Transactions0
No derivative transactions reported